Artia Global Partners Lp Top Holdings and 13F Report (2024) → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) About Artia Global Partners LpInvestment ActivityArtia Global Partners Lp has $497.51 million in total holdings as of March 31, 2024.Artia Global Partners Lp owns shares of 49 different stocks, but just 10 companies or ETFs make up 80% of its holdings.Approximately 29.90% of the portfolio was purchased this quarter.About 15.14% of the portfolio was sold this quarter.This quarter, Artia Global Partners Lp has purchased 31 new stocks and bought additional shares in 13 stocks.Artia Global Partners Lp sold shares of 1 stock and completely divested from 6 stocks this quarter.Largest Holdings ELI LILLY & CO $89,465,400Novo Nordisk A/S $88,819,801Eli Lilly and Company $72,033,650Merck & Co., Inc. $50,035,440Viking Therapeutics $35,553,560 Largest New Holdings this Quarter Vertex Pharmaceuticals $12,080,489 HoldingDisc Medicine $5,419,110 HoldingCrinetics Pharmaceuticals $4,014,660 HoldingDYNE THERAPEUTICS INC $3,392,264 HoldingSpringWorks Therapeutics $2,654,435 Holding Largest Purchases this Quarter ELI LILLY & CO 75,000 shares (about $58.35M)Vertex Pharmaceuticals 28,900 shares (about $12.08M)Intra-Cellular Therapies 168,496 shares (about $11.66M)Merck & Co., Inc. 50,000 shares (about $6.60M)Disc Medicine 87,040 shares (about $5.42M) Largest Sales this Quarter Novo Nordisk A/S 29,764 shares (about $3.82M) Sector Allocation Over TimeMap of 500 Largest Holdings ofArtia Global Partners Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorELI LILLY & CO$89,465,400$58,347,000 ▲187.5%115,00018.0%PUTNVONovo Nordisk A/S$88,819,801$3,821,698 ▼-4.1%691,74317.9%MedicalLLYEli Lilly and Company$72,033,6500.0%92,59314.5%MedicalMRKMerck & Co., Inc.$50,035,440$6,597,500 ▲15.2%379,20010.1%MedicalVKTXViking Therapeutics$35,553,560$4,100,000 ▲13.0%433,5807.1%MedicalABBVAbbVie$16,538,5040.0%90,8213.3%MedicalITCIIntra-Cellular Therapies$14,538,643$11,659,923 ▲405.0%210,0962.9%MedicalARGXargenx$13,480,1850.0%34,2382.7%MedicalAZNAstraZeneca$12,923,4480.0%190,7522.6%MedicalVRTXVertex Pharmaceuticals$12,080,489$12,080,489 ▲New Holding28,9002.4%MedicalAXSMAxsome Therapeutics$7,010,2700.0%87,8481.4%MedicalOCULOcular Therapeutix$6,594,634$2,590,634 ▲64.7%724,6851.3%MedicalCYTKCytokinetics$6,276,598$4,025,155 ▲178.8%89,5251.3%MedicalNBIXNeurocrine Biosciences$6,206,4000.0%45,0001.2%MedicalIRONDisc Medicine$5,419,110$5,419,110 ▲New Holding87,0401.1%MedicalPCVXVaxcyte$5,208,979$2,575,287 ▲97.8%76,2551.0%MedicalAPOGEE THERAPEUTICS INC$4,092,656$3,402,838 ▲493.3%61,5900.8%COMCRNXCrinetics Pharmaceuticals$4,014,660$4,014,660 ▲New Holding85,7650.8%MedicalPTGXProtagonist Therapeutics$3,600,049$350,053 ▲10.8%124,4400.7%MedicalDYNE THERAPEUTICS INC$3,392,264$3,392,264 ▲New Holding119,4880.7%COMINSMInsmed$3,207,743$1,174,729 ▲57.8%118,2360.6%MedicalSWTXSpringWorks Therapeutics$2,654,435$2,654,435 ▲New Holding53,9300.5%MedicalASNDAscendis Pharma A/S$2,402,696$2,402,696 ▲New Holding15,8940.5%MedicalIDYAIDEAYA Biosciences$2,303,349$2,303,349 ▲New Holding52,4920.5%MedicalMRUSMerus$2,259,200$2,259,200 ▲New Holding50,1710.5%MedicalVRNAVerona Pharma$2,104,4110.0%130,7900.4%MedicalALPNAlpine Immune Sciences$2,049,943$2,049,943 ▲New Holding51,7140.4%MedicalCRLCharles River Laboratories International$1,870,9100.0%6,9050.4%MedicalJANXJanux Therapeutics$1,805,280$1,805,280 ▲New Holding47,9490.4%MedicalSLNOSoleno Therapeutics$1,751,547$1,751,547 ▲New Holding40,9240.4%MedicalXENEXenon Pharmaceuticals$1,722,000$1,722,000 ▲New Holding40,0000.3%MedicalARVNArvinas$1,651,200$1,651,200 ▲New Holding40,0000.3%MedicalPLRXPliant Therapeutics$1,490,0000.0%100,0000.3%MedicalMREOMereo BioPharma Group$1,390,485$1,390,485 ▲New Holding421,3590.3%MedicalNAMSNewAmsterdam Pharma$1,283,840$1,283,840 ▲New Holding54,2850.3%MedicalRAPTRAPT Therapeutics$1,233,026$1,056,677 ▲599.2%137,3080.2%MedicalSLNSilence Therapeutics$1,133,482$1,133,482 ▲New Holding52,4760.2%MedicalEYPTEyePoint Pharmaceuticals$1,064,505$31,005 ▲3.0%51,5000.2%MedicalANNXAnnexon$1,057,467$1,057,467 ▲New Holding147,4850.2%MedicalVERAVera Therapeutics$1,047,730$1,047,730 ▲New Holding24,2980.2%MedicalMGNXMacroGenics$942,183$942,183 ▲New Holding64,0070.2%MedicalKURAKura Oncology$842,066$842,066 ▲New Holding39,4780.2%MedicalIMVTImmunovant$691,3370.0%21,3970.1%MedicalBMEABiomea Fusion$530,007$149,500 ▲39.3%35,4520.1%MedicalLRMRLarimar Therapeutics$441,662$441,662 ▲New Holding58,1900.1%MedicalMDGLMadrigal Pharmaceuticals$415,781$415,781 ▲New Holding1,5570.1%MedicalEFFECTOR THERAPEUTICS INC$359,750$359,750 ▲New Holding25,0000.1%CALLPSTXPoseida Therapeutics$274,346$274,346 ▲New Holding86,0020.1%MedicalGRTSGritstone bio$244,5870.0%95,1700.0%MedicalCYTOKINETICS INC$0$33,805,101 ▼-100.0%00.0%CALLCYTOKINETICS INC$0$33,437,745 ▼-100.0%00.0%PUTBMRNBioMarin Pharmaceutical$0$2,785,092 ▼-100.0%00.0%MedicalWATWaters$0$936,659 ▼-100.0%00.0%MedicalSTRUCTURE THERAPEUTICS INC$0$407,600 ▼-100.0%00.0%PUTTYRATyra Biosciences$0$142,004 ▼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.